⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2565949 | 0.82 | FDPS (0.33) | — | |
| SCHEMBL8413930 | 0.79 | — | — | |
| SCHEMBL2565496 | 0.77 | FDPS (0.31) | — | |
| SCHEMBL2565897 | 0.77 | OPRM1 (0.33) | — | |
| SCHEMBL10285142 | 0.77 | TSHR (0.35) | — | |
| SCHEMBL1612949 | 0.77 | TSHR (0.35) | — | |
| SCHEMBL23451479 | 0.74 | — | — | |
| SCHEMBL6050118 | 0.74 | DNM1 (0.36) | — | |
| SCHEMBL5692103 | 0.72 | GABRR1 (0.33) | — | |
| SCHEMBL10371246 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1692112-A4 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS INC (US) | 2008-09-24 | — | — | EP | claimed |
| EP-1594849-A4 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS INC (US) | 2007-07-04 | — | — | EP | claimed |
| JP-2007516434-A | — | — | 2007-06-21 | — | — | JP | claimed |
| EP-1692112-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | Cytokinetics, Inc. (US) | 2006-08-23 | — | — | EP | claimed |
| EP-1692502-A2 | USE OF THE LIPOXIN RECEPTOR, FPRL1, AS A TOOL FOR IDENTIFYING COMPOUNDS EFFECTIVE IN THE TREATMENT OF PAIN AND INFLAMMATION | Acadia Pharmaceuticals Inc. (US) | 2006-08-23 | — | — | EP | claimed |
| EP-1682534-A2 | PYRIMIDIN-4-ONE COMPOUNDS, COMPOSITIONS, AND METHODS | Cytokinetics, Inc. (US) | 2006-07-26 | — | — | EP | claimed |
| EP-1670456-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | Cytokinetics, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1594849-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | Cytokinetics, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2005061460-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS, INC. (US) | 2005-07-07 | — | — | WO | claimed |
| WO-2005047899-A2 | USE OF THE LIPOXIN RECEPTOR, FPRL1, AS A TOOL FOR IDENTIFYING COMPOUNDS EFFECTIVE IN THE TREATMENT OF PAIN AND INFLAMMATION | ACADIA PHARMACEUTICALS INC. (DK) | 2005-05-26 | — | — | WO | claimed |
| WO-2005041888-A2 | PYRIMIDIN-4-ONE COMPOUNDS, COMPOSITIONS AND METHODS | CYTOKINETICS, INC. (US) | 2005-05-12 | — | — | WO | claimed |
| WO-2005042697-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | CYTOKINETICS, INC. (US) | 2005-05-12 | — | — | WO | claimed |
| WO-2004064741-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | CYTOKINETICS INC. (US) | 2004-08-05 | — | — | WO | claimed |
| WO-2001016115-A1 | PROCESS FOR SYNTHESIZING ISOXAZOLIDINES | CHEMRX ADVANCED TECHNOLOGIES, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| WO-2014160811-A1 | COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2014-10-02 | — | — | WO | disclosed |
| EP-2240177-A2 | TREATMENTS FOR NEUROPATHY | Children's Medical Center Corporation (US) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009102570-A2 | TREATMENTS FOR NEUROPATHY | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2009-08-20 | — | — | WO | disclosed |
| WO-2003066580-A1 | PROCESS USING A CYCLIC CARBONATE REACTANT | UCB, S.A. (BE) | 2003-08-14 | — | — | WO | disclosed |
| WO-2001016115-A1 | PROCESS FOR SYNTHESIZING ISOXAZOLIDINES | CHEMRX ADVANCED TECHNOLOGIES, INC. (US) | 2001-03-08 | — | — | WO | disclosed |
| WO-2001016116-A1 | PROCESS FOR SYNTHESIZING ISOXAZOLINES AND ISOXAZOLES | CHEMRX ADVANCED TECHNOLOGIES, INC. (US) | 2001-03-08 | — | — | WO | disclosed |